WORLDWIDE‑CORRUPTION

China · State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Abuse of a dominant market position

潍坊中源医药有限公司

Why it is here

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — abuse of a dominant market position (山东省市场监督管理局山东省市场监督管理局 · 市场监管总局发布潍坊中源医药有限公司滥用市场支配地位案行政处罚决定书), from 18 July 2025.

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Abuse of a dominant market position.

Details

Company
潍坊中源医药有限公司
Authority
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)
Decision
Abuse of a dominant market position
Grounds and details, as published
山东省市场监督管理局山东省市场监督管理局 · 市场监管总局发布潍坊中源医药有限公司滥用市场支配地位案行政处罚决定书
From
18 July 2025
Until
—
Status
End date not published
Source
https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2025/art_6a5011a047e346688459c3a9817d248d.html
Licence
Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)

SourceState Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Abuse of a dominant market position